5,7-dichlorokynurenic acid has been researched along with Craniofacial Pain in 2 studies
5,7-dichlorokynurenic acid: potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, GY | 2 |
| Woo, YW | 1 |
| Park, MK | 2 |
| Bae, YC | 2 |
| Ahn, DK | 2 |
| Bonfa, E | 1 |
| Lee, JH | 1 |
| Won, KA | 1 |
| Kim, MJ | 1 |
| Park, YY | 1 |
2 other studies available for 5,7-dichlorokynurenic acid and Craniofacial Pain
| Article | Year |
|---|---|
Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats.
Topics: Animals; Behavior, Animal; Cisterna Magna; Disease Models, Animal; Excitatory Amino Acid Antagonists | 2010 |
Peripheral administration of NR2 antagonists attenuates orofacial formalin-induced nociceptive behavior in rats.
Topics: Animals; Behavior, Animal; Excitatory Amino Acid Antagonists; Facial Pain; Injections; Kynurenic Aci | 2011 |